(Q27851697)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22190288%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

title

BRCA1 is an essential mediator of vinorelbine-induced apoptosis in mesothelioma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22190288%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

0 references

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22190288%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Steven G Gray

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22190288%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Derek J. Richard

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22190288%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Harvey I Pass

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22190288%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

author name string

Sara Busacca

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22190288%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Michael Sheaff

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22190288%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Kenneth J O'Byrne

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22190288%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Alex Soltermann

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22190288%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Isabelle Opitz

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22190288%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

D Paul Harkin

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22190288%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Jennifer E Quinn

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22190288%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Dean A Fennell

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22190288%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

publication date

19 March 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22190288%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22190288%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

volume

227

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22190288%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22190288%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

page(s)

200-208

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22190288%20AND%20SRC:MED&resulttype=core&format=json

Advances in the systemic therapy of malignant pleural mesothelioma

19 January 2020

cites work

1 reference

Defective core-apoptosis signalling in diffuse malignant pleural mesothelioma: opportunities for effective drug development

21 January 2018

1 reference

Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma

21 January 2018

1 reference

Randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma: an intergroup study of the European Organisation for Research and Treatment of Cancer Lung Cancer Group and the National Cancer Inst

21 January 2018

1 reference

Active symptom control with or without chemotherapy in the treatment of patients with malignant pleural mesothelioma (MS01): a multicentre randomised trial

21 January 2018

1 reference

The efficacy and safety of weekly vinorelbine in relapsed malignant pleural mesothelioma

21 January 2018

1 reference

BRCA1 mRNA expression levels predict for overall survival in ovarian cancer after chemotherapy

21 January 2018

1 reference

BRCA1 and GADD45 mediated G2/M cell cycle arrest in response to antimicrotubule agents

21 January 2018

1 reference

BRCA1 expression modulates chemosensitivity of BRCA1-defective HCC1937 human breast cancer cells

21 January 2018

1 reference

Inhibition of BRCA1 leads to increased chemoresistance to microtubule-interfering agents, an effect that involves the JNK pathway

21 January 2018

1 reference

Correlation of BRCA1, TXR1 and TSP1 mRNA expression with treatment outcome to docetaxel-based first-line chemotherapy in patients with advanced/metastatic non-small-cell lung cancer

21 January 2018

1 reference

Tumor BRCA1, RRM1 and RRM2 mRNA expression levels and clinical response to first-line gemcitabine plus docetaxel in non-small-cell lung cancer patients

21 January 2018

1 reference

BRCA1: a new genomic marker for non-small-cell lung cancer

21 January 2018

1 reference

Immunohistochemical expression of BRCA1 and lethal prostate cancer

21 January 2018

1 reference

Methylation and protein expression of DNA repair genes: association with chemotherapy exposure and survival in sporadic ovarian and peritoneal carcinomas

21 January 2018

1 reference

Localization of human BRCA1 and its loss in high-grade, non-inherited breast carcinomas

21 January 2018

1 reference

BRCA1 and implications for response to chemotherapy in ovarian cancer

21 January 2018

1 reference

Resistance to discodermolide, a microtubule-stabilizing agent and senescence inducer, is 4E-BP1-dependent

21 January 2018

1 reference

Expression of class III {beta}-tubulin is predictive of patient outcome in patients with non-small cell lung cancer receiving vinorelbine-based chemotherapy.

21 January 2018

1 reference

Transcripts in pretreatment biopsies from a three-arm randomized trial in metastatic non-small-cell lung cancer

21 January 2018

1 reference

Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy

21 January 2018

1 reference

Therapeutic potential of poly(ADP-ribose) polymerase inhibitor AG014699 in human cancers with mutated or methylated BRCA1 or BRCA2.

21 January 2018

1 reference

BRCA1 mRNA expression levels as an indicator of chemoresistance in lung cancer

21 January 2018

1 reference

Sporadic epithelial ovarian cancer: clinical relevance of BRCA1 inhibition in the DNA damage and repair pathway

21 January 2018

1 reference

Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers

21 January 2018

1 reference

Breast cancer 1 (BRCA1) protein expression as a prognostic marker in sporadic epithelial ovarian carcinoma: an NCIC CTG OV.16 correlative study

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/PATH.3979

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22190288%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

2 references

13 November 2016